CHAPTER 1.Industry Overview of Platelet and Plasma
1.1.Definition and Scope
1.1.1.Definition of Platelet and Plasma
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Platelet and Plasma Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Platelet and Plasma Market By Component
1.2.3.Platelet and Plasma Market By Distribution Channel
1.2.4.Platelet and Plasma Market By Application
1.2.5.Platelet and Plasma Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Platelet and Plasma Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Platelet and Plasma Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Platelet and Plasma Major Manufacturers in 2020
CHAPTER 5.Platelet and Plasma Market By Component
5.1.Introduction
5.2.Platelet and Plasma Revenue By Component
5.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast, By Component, 2017-2028
5.2.2.Platelets
5.2.2.1.Platelets Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Plasma
5.2.3.1.Plasma Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Platelet and Plasma Market Revenue By Distribution Channel
6.1.Introduction
6.2.Platelet and Plasma Revenue (US$ Mn) By Distribution Channel
6.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
6.2.2.Hospitals
6.2.2.1.Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.Ambulatory surgical centers
6.2.3.1.Ambulatory surgical centers Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Others
6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.Platelet and Plasma Market By Application
7.1.Introduction
7.2.Platelet and Plasma Revenue (US$ Mn) By Application
7.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
7.2.2.Hemophilia
7.2.2.1.Hemophilia Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.3.Thrombocytopenia
7.2.3.1.Thrombocytopenia Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.4.Perioperative indications
7.2.4.1.Perioperative indications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.5.Platelet function disorders
7.2.5.1.Platelet function disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.6.Other platelet applications
7.2.6.1.Other platelet applications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.7.Coagulation factor deficiencies
7.2.7.1.Coagulation factor deficiencies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.8.Thrombotic thrombocytopenic purpura
7.2.8.1.Thrombotic thrombocytopenic purpura Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.9.Hemorrhage
7.2.9.1.Hemorrhage Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.10.Liver disease
7.2.10.1.Liver disease Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.11.Other plasma applications
7.2.11.1.Other plasma applications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8.North America Platelet and Plasma Market By Country
8.1.North America Platelet and Plasma Overview
8.2.U.S.
8.2.1.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
8.2.2.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
8.2.3.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.3.Canada
8.3.1.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
8.3.2.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
8.3.3.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.4.North America PEST Analysis
CHAPTER 9.Europe Platelet and Plasma Market By Country
9.1.Europe Platelet and Plasma Market Overview
9.2.U.K.
9.2.1.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.2.2.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.2.3.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.3.Germany
9.3.1.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.3.2.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.3.3.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.4.France
9.4.1.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.4.2.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.4.3.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.5.Spain
9.5.1.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.5.2.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.5.3.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.6.Rest of Europe
9.6.1.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028
9.6.2.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028
9.6.3.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.7.Europe PEST Analysis
CHAPTER 10.Asia Pacific Platelet and Plasma Market By Country
10.1.Asia Pacific Platelet and Plasma Market Overview
10.2.China
10.2.1.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.2.2.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.2.3.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.3.Japan
10.3.1.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.3.2.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.3.3.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.4.India
10.4.1.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.4.2.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.4.3.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.5.Australia
10.5.1.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.5.2.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.5.3.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.6.South Korea
10.6.1.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.6.2.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.6.3.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.7.Rest of Asia-Pacific
10.7.1.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
10.7.2.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
10.7.3.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
10.8.Asia Pacific PEST Analysis
CHAPTER 11.Latin America Platelet and Plasma Market By Country
11.1.Latin America Platelet and Plasma Market Overview
11.2.Brazil
11.2.1.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
11.2.2.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
11.2.3.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
11.3.Mexico
11.3.1.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
11.3.2.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
11.3.3.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
11.4.Rest of Latin America
11.4.1.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
11.4.2.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027
11.4.3.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
CHAPTER 12.Middle East & Africa Platelet and Plasma Market By Country
12.1.Middle East & Africa Platelet and Plasma Market Overview
12.2.Saudi Arabia
12.2.1.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
12.2.2.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
12.2.3.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.3.UAE
12.3.1.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
12.3.2.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
12.3.3.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
12.4.Rest of Middle East & Africa
12.4.1.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028
12.4.2.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028
12.4.3.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028
CHAPTER 13.Player Analysis Of Platelet and Plasma
13.1.Platelet and Plasma Market Company Share Analysis
13.2.Competition Matrix
13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2.New Product Launches and Product Enhancements
13.2.3.Mergers And Acquisition In Global Platelet and Plasma Market
13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14.COMPANY PROFILE
14.1.Spanish Red Cross
14.1.1.Company Snapshot
14.1.2.Business Overview
14.1.3.Financial Overview
14.1.3.1.Revenue (US$ Mn), 2020
14.1.3.2.Spanish Red Cross 2020 Platelet and Plasma Business Regional Distribution
14.1.4.Product/ Service and Specification
14.1.5.Recent Developments & Business Strategy
14.1.6.Manufacturing Plant Footprint Analysis
14.2.American Red Cross
14.3.America’s Blood Centers
14.4.Blood Centers of America
14.5.European Blood Alliance
14.6.Indian Red Cross Society
14.7.Japanese Red Cross Society
14.8.Red Cross Society of China
14.9.Saudi Red
14.10.Crescent Authority
14.11.Arthrex, Inc.
14.12.South Africa Red Cross Society.
14.13.AdiStem Ltd.
14.14.Others
The market value of platelet and plasma is anticipated to be around US$ 8,000 Mn in 2027.
It is anticipated to grow around 3% CAGR amid the forecast period 2020-2027
North America held maximum share in 2019.
Europe is projected to grow at a fast pace during forecast period from 2020-2027.
Increasing prevalence of liver diseases in elderly population is expected to drive the growth of the platelet and plasma market.
Stringent regulatory policies are a major factor expected to restraint the growth of the market.
Spanish Red Cross, American Red Cross, America’s Blood Centers, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Saudi Red, Crescent Authority, Arthrex, Inc., South Africa Red Cross Society., AdiStem Ltd., and others are the prominent players in the platelet and plasma market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date